Illumina has been contacted by parties interested in Grail: report


Illumina (NASDAQ:ILMN) has reportedly been contacted by parties interested in buying or investing it its Grail cancer test detection unit, which it acquired for around $7B in 2021. Illumina CFO ...

Source Link
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.


We need your insight to fill this gap
Leave a comment